Frontiers in physiology · 2026
Interleukin-13 R130Q aggravates airway smooth-muscle phenotypic switching and promotes airway remodeling in severe asthma.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
He Yafang, Sun Jingyi, Li Luanluan, Bai Shasha, Zhai Xiaojia, Tian Ye, Pan Qin, Bao Yixiao, Ding Guodong
Аннотация
INTRODUCTION: Airway remodeling represents a key pathological feature of severe asthma. Although the interleukin-13 (IL-13) R130Q variant is associated with increased disease severity, its specific contribution to airway remodeling remains unclear.
METHODS: This study used an ovalbumin (OVA)-induced asthma model in which mice were sensitized intraperitoneally with OVA/alum and subsequently challenged intranasally with OVA; human IL-13 130R or IL-13 130Q was administered intranasally before each challenge. Primary human bronchial smooth muscle cells (hBSMCs) from a single healthy donor were treated with both variants to assess CCK-8-derived proliferative/metabolic activity, migration, acetylcholine (ACh)-induced intracellular calcium responses, and IL-4 and IL-5 concentrations in culture supernatants. JAK2 and STAT6 phosphorylation was evaluated separately as a downstream signaling readout. Structural modeling and independent triplicate 100-ns molecular dynamics simulations of the IL-13/IL-13 receptor alpha 2 (IL-13Rα2) complex were performed using GROMACS 2025.4 with the AMBER ff19SB force field, and molecular mechanics/generalized Born surface area analysis was used for relative comparison of binding free energies.
RESULTS: IL-13 130Q produced limited airway changes in mice without OVA sensitization, but exacerbated airway wall thickening, luminal narrowing, smooth-muscle expansion, and pulmonary inflammation in OVA-sensitized and intranasally challenged mice. In hBSMCs, IL-13 130Q induced greater CCK-8-derived proliferative/metabolic activity, migration, ACh-induced intracellular calcium responses, and IL-4 and IL-5 concentrations than IL-13 130R at 10 -100 ng/mL. Molecular dynamics analyses suggested the reduced binding stability of IL-13 130Q/IL-13Rα2 complex, as reflected by fewer interfacial hydrogen bonds, altered intermolecular contacts, and a less favorable relative binding free energy. Elevated JAK2/STAT6 phosphorylation indicated the amplification of downstream signaling, mechanistically tied to potential reduced decoy-receptor affinity.
CONCLUSION: These preclinical data support a contextdependent potentiating function of IL13 130Q in airway smoothmuscle phenotypic modulation and airway remodeling. Further investigation may rationalize genotype-based stratification in the therapy of severe asthma.
METHODS: This study used an ovalbumin (OVA)-induced asthma model in which mice were sensitized intraperitoneally with OVA/alum and subsequently challenged intranasally with OVA; human IL-13 130R or IL-13 130Q was administered intranasally before each challenge. Primary human bronchial smooth muscle cells (hBSMCs) from a single healthy donor were treated with both variants to assess CCK-8-derived proliferative/metabolic activity, migration, acetylcholine (ACh)-induced intracellular calcium responses, and IL-4 and IL-5 concentrations in culture supernatants. JAK2 and STAT6 phosphorylation was evaluated separately as a downstream signaling readout. Structural modeling and independent triplicate 100-ns molecular dynamics simulations of the IL-13/IL-13 receptor alpha 2 (IL-13Rα2) complex were performed using GROMACS 2025.4 with the AMBER ff19SB force field, and molecular mechanics/generalized Born surface area analysis was used for relative comparison of binding free energies.
RESULTS: IL-13 130Q produced limited airway changes in mice without OVA sensitization, but exacerbated airway wall thickening, luminal narrowing, smooth-muscle expansion, and pulmonary inflammation in OVA-sensitized and intranasally challenged mice. In hBSMCs, IL-13 130Q induced greater CCK-8-derived proliferative/metabolic activity, migration, ACh-induced intracellular calcium responses, and IL-4 and IL-5 concentrations than IL-13 130R at 10 -100 ng/mL. Molecular dynamics analyses suggested the reduced binding stability of IL-13 130Q/IL-13Rα2 complex, as reflected by fewer interfacial hydrogen bonds, altered intermolecular contacts, and a less favorable relative binding free energy. Elevated JAK2/STAT6 phosphorylation indicated the amplification of downstream signaling, mechanistically tied to potential reduced decoy-receptor affinity.
CONCLUSION: These preclinical data support a contextdependent potentiating function of IL13 130Q in airway smoothmuscle phenotypic modulation and airway remodeling. Further investigation may rationalize genotype-based stratification in the therapy of severe asthma.